Clinical Trial Update: A Comprehensive Register Of Lymphoproliferative Disorders (ReLy)

View source ↗

Summary

This trial registration update notes that the ReLy registry study for lymphoproliferative disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorders

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Lymphoproliferative Disease | Status: RECRUITING